Developing the Next Big Vaccine Technologies
Summary: We are in a new era of possibilities with vaccines. The rapid development of safe and efficacious mRNA vaccines was a triumph for biopharma that has propelled the entire vaccine field–once relegated to the backwaters of biotech R&D–straight into a first-class concern for investors and dealmakers. In this executive summary, some of the field’s top experts weigh in on the techniques and technologies they are working on, including self-amplifying RNA, computer-designed nanoparticles, expanding mRNA processes and the challenges of scaling these new technologies.